Dendreon
Dendreon is a biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells (autologous, with dendritic cells thought to be the most important) that have been incubated with the Dendreon PAP-GM-CSF fusion protein.Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by the FDA on April 29, 2010. Dendreon's stock value fell 66% on August 4, 2011, after abandoning its forecast for its debut drug Provenge.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Dendreon
Dendreon is a biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells (autologous, with dendritic cells thought to be the most important) that have been incubated with the Dendreon PAP-GM-CSF fusion protein.Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by the FDA on April 29, 2010. Dendreon's stock value fell 66% on August 4, 2011, after abandoning its forecast for its debut drug Provenge.
has abstract
Dendreon is a biotechnology co ...... from Valeant for $820 million.
@en
industry
number of employees
parent company
product
service
Link from a Wikipage to an external page
Wikipage page ID
26,400,298
page length (characters) of wiki page
Wikipage revision ID
1,019,616,228
Link from a Wikipage to another Wikipage
industry
location city
location country
US
@en
logo
@en
name
Dendreon
@en
num employees
parent
Sanpower Group, Nanjing, CN
@en
products
Provenge
@en
services
Provenge
@en
wikiPageUsesTemplate
wordnet_type
subject
hypernym
point
47.607948 -122.338547
comment
Dendreon is a biotechnology co ...... t for its debut drug Provenge.
@en
label
Dendreon
@en
lat
4.7607948e+1
long
-1.22338547e+2
closeMatch
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Dendreon
@en